language-icon Old Web
English
Sign In
Acemap > Paper > EGFR,HER2及びHER3阻害剤AZD8931の第1相試験-進行固形癌患者対象の単独投与及び進行再発乳癌患者対象のパクリタキセル併用-

EGFR,HER2及びHER3阻害剤AZD8931の第1相試験-進行固形癌患者対象の単独投与及び進行再発乳癌患者対象のパクリタキセル併用-

2013 
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []
    logo
    • CCF Conference Analysis
    • Map Galaxy
    • What's New
    © Copyright 2015-2020 Acemap, Inc. Shanghai Jiao Tong University.